-The Patient Advocacy Organization POIC e dintorni APS and Dante Genomics forge an alliance to offer whole genome sequencing solutions to patients with rare diseases, a partnership presented at the 2nd World Congress of Pediatric Neurogastroenterology and Motility
NEW YORK, Sept. 11, 2023 /PRNewswire/ — POIC e dintorni APS and Dante Genomics, a global leader in genomics and precision medicine, have embarked on a pioneering collaboration to accelerate whole genome sequencing solutions for patients with ACTG2-mediated microcolon intestinal hypoperistalsis syndrome (MMIHS) and chronic intestinal pseudo-obstruction (CIPO). This strategic partnership is poised to make significant advances in the understanding and treatment of these complex and rare disorders, with a featured presentation at the 2nd World Congress of Pediatric Neurogastroenterology and Motility, held September 7-9, 2023 in Columbus, Ohio (USA).
This innovative partnership is set to achieve three key objectives:
The 2nd World Congress of Pediatric Neurogastroenterology and Motility is the perfect setting for the presentation of the association. This international event brings together the sector’s leading experts, researchers and medical professionals to share knowledge, advances and innovations. POIC e dintorni and Dante Genomics will present their collaborative efforts through presentations, interactive sessions and informational booths, facilitating meaningful discussions and knowledge sharing.
“As the mother of a daughter affected by CIPO since birth and as President of a patient organization that supports the defense of chronic intestinal pseudo-obstruction, I am very excited about the potential that this alliance with Dante Genomics offers us. It clearly demonstrates the joint commitment to improve the quality of life of patients. Together, we are prepared to make significant progress,” said Ornella Spada, president and co-founder of Poic e dintorni APS. “Starting today, the word hope has a new and encouraging meaning for families, caregivers and patients affected by CIPO.”
“This partnership reflects our shared commitment to pushing the boundaries of personalized medicine with genomic solutions,” said Andrea Riposati, co-founder and CEO of Dante Genomics. “By showcasing our efforts at the 2nd World Congress, we aim to build support and foster relationships with leaders in genomics and pediatric medicine to leverage the clinical utility of the genome for rare disease patients around the world.”
About POIC Associazione Poic e Dintorni APS – a patient advocacy organization, is a leading organization dedicated to improving the care and well-being of children with ostomies and incontinence. POIC fosters collaboration between clinicians, researchers and families to drive innovation in pediatric healthcare.
About Dante Genomics Dante Genomics is a global genomics information company creating and commercializing a new class of transformative health and longevity applications based on whole genome sequencing and software. The company uses its platform to deliver better patient outcomes, prevention, improved diagnostics and personalized medicine. The company’s assets include one of the largest private, research-consented genomic databases, proprietary software designed to unleash the power of genomic data at scale, and proprietary processes that enable an industrial approach to genomic sequencing.
About the 2nd World Congress of Pediatric Neurogastroenterology and MotilityThe 2nd World Congress of Pediatric Neurogastroenterology and Motility is a premier international event dedicated to advancing research, collaboration and clinical care in the field of pediatric neurogastroenterology and motility. The congress brings together leading experts and professionals to share knowledge and innovations.
Contact: Laura D’AngeloVP of Investor Relations ir@dantelabs.com 39 0862 191 0671 www.dantegenomics.com
Logo – https://mma.prnewswire.com/media/2035834…Logo – https://mma.prnewswire.com/media/2206902…
View original content: https://www.prnewswire.com/news-releases/colaboracion-entre-la-organizacion-de-defensa-del-paciente-poic-e-dintorni-aps-y-dante-genomics-301923674.html
